FDA — authorised 2 August 1990
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: approved
FDA authorised Alevaire on 2 August 1990
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 2 August 1990.
GLAXOSMITHKLINE holds the US marketing authorisation.